GLANBIA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.86 EUR | +0.96% |
|
+0.90% | +19.79% |
| Sales 2024 * | 5.08B 5.43B 453B | Sales 2025 * | 4.26B 4.56B 380B | Capitalization | 4.66B 4.99B 416B |
|---|---|---|---|---|---|
| Net income 2024 * | 286M 306M 25.51B | Net income 2025 * | 305M 326M 27.2B | EV / Sales 2024 * | 0.95 x |
| Net Debt 2024 * | 165M 177M 14.75B | Net cash position 2025 * | 56.16M 60.05M 5.01B | EV / Sales 2025 * | 1.08 x |
| P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
15.2
x | Employees | 5,534 |
| Yield 2024 * |
2.12% | Yield 2025 * |
2.28% | Free-Float | 69.87% |
More Fundamentals
* Assessed data
More news
Latest transcript on Glanbia plc
More news
| 1 day | +0.96% | ||
| 1 week | +0.90% | ||
| Current month | -2.30% | ||
| 1 month | -2.08% | ||
| 3 months | +13.04% | ||
| 6 months | +21.66% | ||
| Current year | +19.79% |
1 week
17.49
18.00
1 month
17.3918.46
Current year
14.6118.54
1 year
13.1218.54
3 years
9.7118.54
5 years
7.4418.54
10 years
7.4419.60
| Managers | Title | Age | Since |
|---|---|---|---|
Hugh McGuire
CEO | Chief Executive Officer | 53 | 01/01 |
Mark Garvey
DFI | Director of Finance/CFO | 60 | 12/13/12 |
Liam Hennigan
IRO | Public Communications Contact | - | 01/14/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel O'Connor
BRD | Director/Board Member | 63 | 01/14/01 |
Jane Lodge
BRD | Director/Board Member | 68 | 01/20/01 |
Róisín Brennan
BRD | Director/Board Member | 59 | 01/21/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.04% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 17.86 | +0.96% | 217,906 |
| 25/24/25 | 17.69 | -0.34% | 224,382 |
| 24/24/24 | 17.75 | -0.50% | 210,379 |
| 23/24/23 | 17.84 | 0.00% | 135,368 |
| 22/24/22 | 17.84 | +0.79% | 102,134 |
Real-time Irish S.E., April 26, 2024 at 09:25 pm IST
More quotes
Glanbia plc specializes in the production and commercialization of dairy, nutritional and food products for the food and pharmaceutical industries. Net sales break down by product family as follows:
- nutritional and functional ingredients (66.9%): dairy, vegetable and functional proteins, nutrients (vitamins, trace elements, minerals, etc.), nutritional supplements for children, bioactive ingredients, etc. for dairy and non-dairy products (drinks, cereal bars, snacks, sauces, animal feed, etc.). The group is also developing a cheese production activity;
- performance nutrition products (33.1%; world n°1): notably sports nutrition products (Optimum Nutrition, BSN, Isopure, thinkThin, Nutramino, ABB, Body & Fit and Amazing Grass brands).
Net sales are distributed geographically as follows: Ireland (0.3%), Europe (8.7%), the United States (79.2%), North America (2%), Asia/Pacific (7%), Latin America (1.8%) and other (1%).
Sector
Food Processing
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
17.86
EUR
Average target price
20.38
EUR
Spread / Average Target
+14.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.79% | 4.98B | |
| +4.71% | 24.52B | |
| -23.24% | 8.1B | |
| -4.24% | 6.82B | |
| +8.16% | 6.26B | |
| -3.85% | 5.36B | |
| -3.18% | 5.16B | |
| +1.41% | 5.02B | |
| +22.01% | 4.53B | |
| -3.99% | 2.92B |
- Stock Market
- Equities
- GL9 Stock
